WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+9.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$11.8B
AUM Growth
+$1.41B
(+13%)
Cap. Flow
+$896M
Cap. Flow
% of AUM
7.57%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
744
New
202
Increased
220
Reduced
152
Closed
160
Top Buys
| 1 |
ASML
ASML
|
$125M |
| 2 |
Meta Platforms (Facebook)
META
|
$100M |
| 3 |
STMicroelectronics
STM
|
$92.5M |
| 4 |
MetLife
MET
|
$79.4M |
| 5 |
Gilead Sciences
GILD
|
$77.3M |
Top Sells
| 1 |
TE Connectivity
TEL
|
$161M |
| 2 |
Eli Lilly
LLY
|
$151M |
| 3 |
Marsh & McLennan
MMC
|
$123M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$86.7M |
| 5 |
Electronic Arts
EA
|
$78.6M |
Sector Composition
| 1 | Healthcare | 43.57% |
| 2 | Technology | 17.47% |
| 3 | Industrials | 8.1% |
| 4 | Energy | 6.42% |
| 5 | Financials | 6.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
SharkNinja
SN
$16.5B
| $5.52M | 0.05% |
50,747
-169,696
| -77% | -$18.4M |
|
377
Apellis Pharmaceuticals
APLS
$3.55B
| $5.44M | 0.05% |
188,564
+1,564
| +0.8% | +$45.1K |
|
378
ITT
ITT
$13.3B
| $5.34M | 0.04% |
+35,691
| New | +$5.34M |
|
379
Legend Biotech
LEGN
$6.66B
| $5.33M | 0.04% |
109,395
+9,394
| +9% | +$458K |
|
380
RTX Corp
RTX
$211B
| $5.32M | 0.04% |
+43,890
| New | +$5.32M |
|
381
Iovance Biotherapeutics
IOVA
$901M
| $5.28M | 0.04% |
+562,435
| New | +$5.28M |
|
|
INZY
382
DELISTED
Inozyme Pharma
INZY
| $5.25M | 0.04% |
1,003,124
+2,451
| +0.2% | +$12.8K |
|
383
NXP Semiconductors
NXPI
$57.2B
| $5.2M | 0.04% |
+21,670
| New | +$5.2M |
|
384
Enovis
ENOV
$1.84B
| $5.12M | 0.04% |
+119,000
| New | +$5.12M |
|
385
Guidewire Software
GWRE
$22B
| $5.09M | 0.04% |
+27,827
| New | +$5.09M |
|
386
Domo
DOMO
$603M
| $5.03M | 0.04% |
669,584
+336,117
| +101% | +$2.52M |
|
387
Sweetgreen
SG
$1.06B
| $5M | 0.04% |
+141,126
| New | +$5M |
|
388
Textron
TXT
$14.5B
| $4.99M | 0.04% |
56,307
-239,384
| -81% | -$21.2M |
|
389
Warner Bros
WBD
$30B
| $4.81M | 0.04% |
+583,154
| New | +$4.81M |
|
390
Q32 Bio
QTTB
$20.4M
| $4.77M | 0.04% |
+106,901
| New | +$4.77M |
|
|
WAY
391
Waystar Holding Corp
WAY
$6.49B
| $4.72M | 0.04% |
169,327
-31,481
| -16% | -$878K |
|
392
CRISPR Therapeutics
CRSP
$4.99B
| $4.7M | 0.04% |
100,000
-26,839
| -21% | -$1.26M |
|
393
Humacyte
HUMA
$226M
| $4.62M | 0.04% |
+848,534
| New | +$4.62M |
|
394
Willis Towers Watson
WTW
$32.1B
| $4.53M | 0.04% |
+15,390
| New | +$4.53M |
|
395
FIVE9
FIVN
$2.06B
| $4.5M | 0.04% |
156,553
+101,718
| +185% | +$2.92M |
|
|
OS
396
OneStream, Inc. Class A Common Stock
OS
$3.68B
| $4.49M | 0.04% |
+132,385
| New | +$4.49M |
|
397
EverCommerce
EVCM
$2.06B
| $4.44M | 0.04% |
428,735
+124,698
| +41% | +$1.29M |
|
398
FerroAtlántica
GSM
$799M
| $4.43M | 0.04% |
+955,793
| New | +$4.43M |
|
399
Recursion Pharmaceuticals
RXRX
$2.01B
| $4.42M | 0.04% |
671,319
+6,869
| +1% | +$45.3K |
|
400
NVIDIA
NVDA
$4.07T
| $4.39M | 0.04% |
36,163
-107,390
| -75% | -$13M |
|